Latest news
Nurix Therapeutics, Inc. (NRIX) Latest Stock News & Headlines - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 16:44:51 GMTNRIX (NRIX) holder Hansen details option exercise and 10b5-1 stock sales - Stock TitanStock Titan · Wed, 05 Aug 2026 20:24:35 GMTNRIX (NRIX) holder files to sell 4,761 shares after recent 10b5-1 sales - Stock TitanStock Titan · Tue, 04 Aug 2026 20:35:15 GMTNRIX (NASDAQ: NRIX) insider files to sell 4,111 shares and details 10b5-1 trades - Stock TitanStock Titan · Tue, 04 Aug 2026 20:34:38 GMTNurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMTNurix Starts Phase 3 Trial of Bexobrutideg Against Pirtobrutinib in CLL - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 06:33:26 GMTNurix Therapeutics Announces First Patient Enrolled in Phase 3 DAYBreak CLL-306 Study of Bexobrutideg in Relapsed/Refractory CLL/SLL - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 05:10:00 GMTNurix Phase 3 Trial Tests Bexobrutideg Against CLL Standard of Care - Stock TitanStock Titan · Tue, 04 Aug 2026 05:03:02 GMT